Characterisation of paediatric brain tumours by their MRS metabolite profiles
Simrandip K. Gill,Heather E. L. Rose,Martin Wilson,Daniel Rodriguez Gutierrez,Lara Worthington,Nigel P. Davies,Lesley MacPherson,Darren R. Hargrave,Dawn E. Saunders,Christopher A. Clark,Geoffrey S. Payne,Martin O. Leach,Franklyn A. Howe,Dorothee P. Auer,Tim Jaspan,Paul S. Morgan,Richard G. Grundy,Shivaram Avula,Barry Pizer,Theodoros N. Arvanitis,Andrew C. Peet
DOI: https://doi.org/10.1002/nbm.5101
2024-02-02
NMR in Biomedicine
Abstract:Single‐voxel 1H magnetic resonance spectroscopy was performed for a suspected brain tumour on 340 children from five hospitals. Mean spectra and metabolite concentrations were found to differ significantly between tumour types. Machine learning classifiers built using the metabolite profiles had 93% accuracy for determining the diagnosis of three main tumour types. Children's brain tumours are characterised by their metabolite profiles, which can be used to support noninvasive diagnosis. 1H‐magnetic resonance spectroscopy (MRS) has the potential to improve the noninvasive diagnostic accuracy for paediatric brain tumours. However, studies analysing large, comprehensive, multicentre datasets are lacking, hindering translation to widespread clinical practice. Single‐voxel MRS (point‐resolved single‐voxel spectroscopy sequence, 1.5 T: echo time [TE] 23–37 ms/135–144 ms, repetition time [TR] 1500 ms; 3 T: TE 37–41 ms/135–144 ms, TR 2000 ms) was performed from 2003 to 2012 during routine magnetic resonance imaging for a suspected brain tumour on 340 children from five hospitals with 464 spectra being available for analysis and 281 meeting quality control. Mean spectra were generated for 13 tumour types. Mann–Whitney U‐tests and Kruskal–Wallis tests were used to compare mean metabolite concentrations. Receiver operator characteristic curves were used to determine the potential for individual metabolites to discriminate between specific tumour types. Principal component analysis followed by linear discriminant analysis was used to construct a classifier to discriminate the three main central nervous system tumour types in paediatrics. Mean concentrations of metabolites were shown to differ significantly between tumour types. Large variability existed across each tumour type, but individual metabolites were able to aid discrimination between some tumour types of importance. Complete metabolite profiles were found to be strongly characteristic of tumour type and, when combined with the machine learning methods, demonstrated a diagnostic accuracy of 93% for distinguishing between the three main tumour groups (medulloblastoma, pilocytic astrocytoma and ependymoma). The accuracy of this approach was similar even when data of marginal quality were included, greatly reducing the proportion of MRS excluded for poor quality. Children's brain tumours are strongly characterised by MRS metabolite profiles readily acquired during routine clinical practice, and this information can be used to support noninvasive diagnosis. This study provides both key evidence and an important resource for the future use of MRS in the diagnosis of children's brain tumours.
radiology, nuclear medicine & medical imaging,biophysics,spectroscopy